UK approves Wegovy as daily oral weight‑loss pill

Britain’s MHRA has approved Wegovy as an oral, once‑daily tablet for weight loss, a first for the drug, with prescription access opening soon though NHS funding awaits NICE’s decision. The tablet starts at 1.5 mg daily and can rise to 4 mg, 9 mg and 25 mg, taken on an empty stomach and without refrigeration; patients currently using the injection can switch to the 25 mg tablet. Availability is expected through pharmacies, while cost is not yet announced (US pricing had a starting dose around $149/month). Side effects mirror the injectable form and long‑term weight management still requires diet and exercise, with weight potentially returning after stopping.